The microfibril-associated glycoproteins (MAGPs) and the microfibrillar niche

Matrix Biology

Volumn 47, Issue , 2015, Pages 13-33

  Mecham, Robert P ^a   Gibson, Mark A ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Diabetes; Fibrilin; MAGP; Microfibril; Microfibril associated glycoprotein; Obesity; Osteoporosis; TGF

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; FIBRILLIN; GLYCOPROTEIN; GROWTH FACTOR; MICROFIBRIL ASSOCIATED GLYCOPROTEIN; MICROFIBRIL ASSOCIATED GLYCOPROTEIN 1; MICROFIBRIL ASSOCIATED GLYCOPROTEIN 2; NOTCH RECEPTOR; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; ACTIN BINDING PROTEIN; CONTRACTILE PROTEIN; MICROFIBRILLAR PROTEIN;

ADIPOSE TISSUE; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; BLEEDING TENDENCY; BLOOD VESSEL WALL; BONE DEFECT; CARBOXY TERMINAL SEQUENCE; DIABETES MELLITUS; ELASTIC FIBER; GENE INACTIVATION; GENE STRUCTURE; HEMATOPOIESIS; HOMEOSTASIS; HUMAN; LIPID STORAGE; NEUTROPENIA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SULFATION; WOUND HEALING IMPAIRMENT; ZEBRA FISH; ANIMAL; BONE DEVELOPMENT; FIBER; GENE EXPRESSION; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN PROCESSING; WOUND HEALING;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BONE DEVELOPMENT; CONTRACTILE PROTEINS; EXTRACELLULAR MATRIX PROTEINS; FIBRILLINS; GENE EXPRESSION; GLYCOPROTEINS; HEMATOPOIESIS; HUMANS; MICROFIBRILS; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN PROCESSING, POST-TRANSLATIONAL; WOUND HEALING;

EID: 84943665548     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2015.05.003     Document Type: Review

References (131)

1. Sakai L.Y., Keene D.R., Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J. Cell Biol. 1986, 103:2499-2509.
2. Jensen S.A., Robertson I.B., Handford P.A. Dissecting the fibrillin microfibril: structural insights into organization and function. Structure 2012, 20:215-225.
3. Kielty C.M., Sherratt M.J., Marson A., Baldock C. Fibrillin microfibrils. Adv. Protein Chem. 2005, 70:405-436.
4. Robertson I., Jensen S., Handford P. TB domain proteins: evolutionary insights into the multifaceted roles of fibrillins and LTBPs. Biochem. J. 2011, 433:263-276.
5. Hynes R.O. The evolution of metazoan extracellular matrix. J. Cell Biol. 2012, 196:671-679.
6. Segade F. Molecular evolution of the microfibril-associated proteins: The fibulins and the MAGPs. Evolution of Extracellular Matrix 2013, 163-190.
7. Sakamoto H., Broekelmann T., Cheresh D.A., Ramirez F., Rosenbloom J., Mecham R.P. Cell-type specific recognition of RGD- and non-RGD-containing cell binding domains in fibrillin-1. J. Biol. Chem. 1996, 271:4916-4922.
8. Bax D.V., Bernard S.E., Lomas A., Morgan A., Humphries J., Shuttleworth C.A., et al. Cell adhesion to fibrillin-1 molecules and microfibrils is mediated by alpha 5 beta 1 and alpha v beta 3 integrins. J. Biol. Chem. 2003, 278:34605-34616.
9. Gibson M.A., Leavesley D.I., Ashman L.K. Microfibril-associated glycoprotein-2 specifically interacts with a range of bovine and human cell types via αvβ3 integrins. J. Biol. Chem. 1999, 274:13060-13065.
10. Bax D.V., Rodgers U.R., Bilek M.M., Weiss A.S. Cell adhesion to tropoelastin is mediated via the C-terminal GRKRK motif and integrin αVβ3. J. Biol. Chem. 2009, 284:28616-28623.
11. Colombatti A., Spessotto P., Doliana R., Mongiat M., Bressan G.M., Esposito G. The EMILIN/Multimerin family. Front. Immunol. 2011, 2:93.
12. Yanagisawa H., Davis E.C., Starcher B.C., Ouchi T., Yanagisawa M., Richardson J.A., et al. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 2002, 415:168-171.
13. Nakamura T., Lozano P.R., Ikeda Y., Iwanaga Y., Hinek A., Minamisawa S., et al. Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 2002, 415:171-175.
14. Miyamoto A., Lau R., Hein P.W., Shipley J.M., Weinmaster G. Microfibrillar proteins MAGP-1 and MAGP-2 induce Notch1 extracellular domain dissociation and receptor activation. J. Biol. Chem. 2006, 281:10089-10097.
15. Broekelmann T.J., Kozel B.A., Ishibashi H., Werneck C.C., Keeley F.W., Zhang L., et al. Tropoelastin interacts with cell-surface glycosaminoglycans via its C-terminal domain. J. Biol. Chem. 2005, 280:40939-40947.
16. Hinek A., Bodnaruk T.D., Bunda S., Wang Y., Liu K. Neuraminidase-1, a subunit of the cell surface elastin receptor, desialylates and functionally inactivates adjacent receptors interacting with the mitogenic growth factors PDGF-BB and IGF-2. Am. J. Pathol. 2008, 173:1042-1056.
17. Ramirez F., Sakai L.Y., Rifkin D.B., Dietz H.C. Extracellular microfibrils in development and disease. Cell. Mol. Life Sci. 2007, 64:2437-2446.
18. Isogai Z., Ono R.N., Ushiro S., Keene D.R., Chen Y., Mazzieri R., et al. Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J. Biol. Chem. 2003, 278:2750-2757.
19. Zacchigna L., Vecchione C., Notte A., Cordenonsi M., Dupont S., Maretto S., et al. Emilin1 links TGF-beta maturation to blood pressure homeostasis. Cell 2006, 124:929-942.
20. Weinbaum J.S., Broekelmann T.J., Pierce R.A., Werneck C.C., Segade F., Craft C.S., et al. Deficiency in Microfibril-associated Glycoprotein-1 Leads to Complex Phenotypes in Multiple Organ Systems. J. Biol. Chem. 2008, 283:25533-25543.
21. Abrams W.R., Ma R.I., Kucich U., Bashir M.M., Decker S., Tsipouras P., et al. Molecular cloning of the microfibrillar protein MFAP3 and assignment of the gene to human chromosome 5q32-q33.2. Genomics 1995, 26:47-54.
22. Horrigan S.K., Rich C.B., Streeten B.W., Li Z.Y., Foster J.A. Characterization of an associated microfibril protein through recombinant DNA techniques. J. Biol. Chem. 1992, 267:10087-10095.
23. Toyoshima T., Nishi N., Kusama H., Kobayashi R., Itano T. 36-kDa microfibril-associated glycoprotein (MAGP-36) is an elastin-binding protein increased in chick aortae during development and growth. Exp. Cell Res. 2005, 307:224-230.
24. Zhao Z., Lee C.C., Jiralerspong S., Juyal R.C., Lu F., Baldini A., et al. The gene for a human microfibril-associated glycoprotein is commonly deleted in Smith-Magenis syndrome patients. Hum. Mol. Genet. 1995, 4:589-597.
25. Andersen D.S., Tapon N. Drosophila MFAP1 is required for pre-mRNA processing and G2/M progression. J. Biol. Chem. 2008, 283:31256-31267.
26. Ma L., Gao X., Luo J., Huang L., Teng Y., Horvitz H.R. The Caenorhabditis elegans gene mfap-1 encodes a nuclear protein that affects alternative splicing. PLoS Genet. 2012, 8:e1002827.
27. Lou X., Kang B., Zhang J., Hao C., Tian X., Li W., et al. MFAP3L activation promotes colorectal cancer cell invasion and metastasis. Biochim. Biophys. Acta 2014, 1842:1423-1432.
28. Gibson M.A. Marfan Syndrome: A primer for Clinicians and Scientists 2004, 161-177. Springer, Berlin. P.N. Robinson, M. Godfrey (Eds.).
29. Cleary E.G., Gibson M.A. Elastin-associated microfibrils and microfibrillar proteins. Int. Rev. Connect. Tiss. Res. 1983, 10:97-209.
30. Prosser I.W., Gibson M.A., Cleary E.G. Microfibrillar protein from elastic tissue: A critical evaluation. Aust. J. Exp. Biol. Med. Sci. 1984, 62:287-294.
31. Gibson M.A., Hughes J.L., Fanning J.C., Cleary E.G. The major antigen of elastin-associated microfibrils is a 31-kDa glycoprotein. J. Biol. Chem. 1986, 261:11429-11436.
32. Gibson M.A., Hatzinikolas G., Kumaratilake J.S., Sandberg L.B., Nicholl J.K., Sutherland G.R., et al. Further characterization of proteins associated with elastic fiber microfibrils including the molecular cloning of MAGP-2 (MP25). J. Biol. Chem. 1996, 271:1096-1103.
33. Keene D.R., Maddox B.K., Kuo H.J., Sakai L.Y., Glanville R.W. Extraction of extendable beaded structures and their identification as fibrillin-containing extracellular matrix microfibrils. J. Histochem. Cytochem. 1991, 39:441-449.
34. Henderson M., Polewski R., Fanning J.C., Gibson M.A. Microfibril-associated glycoprotein-1 (MAGP-1) is specifically located on the beads of the beaded-filament structure of fibrillin-containing microfibrils as visualized by the rotary shadowing technique. J. Histochem. Cytochem. 1996, 44:1389-1397.
35. Gibson M.A., Sandberg L.B., Grosso L.E., Cleary E.G. Complementary DNA cloning establishes microfibril-associated glycoprotein (MAGP) to be a discrete component of the elastin-associated microfibrils. J. Biol. Chem. 1991, 266:7596-7601.
36. Trask B.C., Broekelmann T.J., Mecham R.P. Post-translational modifications of microfibril associated glycoprotein-1 (MAGP-1). Biochemistry 2001, 40:4372-4380.
37. Aggeli A., Bell M., Boden N., Keen J.N., Knowles P.F., McLeish T.C., et al. Responsive gels formed by the spontaneous self-assembly of peptides into polymeric beta-sheet tapes. Nature 1997, 386:259-262.
38. Segade F. Functional evolution of the microfibril-associated glycoproteins. Gene 2009, 439:43-54.
39. Sage H., Gray W.R. Studies on the evolution of elastin--I Phylogenetic distribution. Comp. Biochem. Physiol. B 1979, 64:313-327.
40. Sage H. The evolution of elastin: correlation of functional properties with protein structure and phylogenetic distribution. Comp. Biochem. Physiol. B 1983, 74:373-380.
41. Faraco J., Bashir M., Rosenbloom J., Francke U. Characterization of the human gene for microfibril-associated glycoprotein (MFAP2), assignment to chromosome 1P36.1-P35, and linkage to D1S170. Genomics 1995, 25:630-637.
42. Chen Y., Faraco J., Yin W., Germiller J., Francke U., Bonadio J. Structure, chromosomal localization, and expression pattern of the murine Magp gene. J. Biol. Chem. 1993, 268:27381-27389.
43. Segade F., Broekelmann T.J., Pierce R.A., Mecham R.P. Revised genomic structure of the human MAGP1 gene and identification of alternate transcripts in human and mouse tissues. Matrix Biol. 2000, 19:671-682.
44. Segade F., Mecham R.P. Regulatory elements of microfibril-associated glycoprotein-1 gene expression in muscle cells. Biochim. Biophys. Acta 2005, 1731:215-224.
45. Segade F., Suganuma N., Mychaleckyj J.C., Mecham R.P. The intracellular form of human MAGP1 elicits a complex and specific transcriptional response. Int. J. Biochem. Cell Biol. 2007, 39:2303-2313.
46. Dong J., Jiang G., Asmann Y.W., Tomaszek S., Jen J., Kislinger T., et al. MicroRNA networks in mouse lung organogenesis. PLoS One 2010, 5:e10854.
47. Brown-Augsburger P., Broekelmann T., Mecham L., Mercer R., Gibson M.A., Cleary E.G., et al. Microfibril-associated glycoprotein (MAGP) binds to the carboxy-terminal domain of tropoelastin and is a substrate for transglutaminase. J. Biol. Chem. 1994, 269:28443-28449.
48. Jensen S.A., Reinhardt D.P., Gibson M.A., Weiss A.S. Protein interaction studies of MAGP-1 with tropoelastin and fibrillin-1. J. Biol. Chem. 2001, 276:39661-39666.
49. Ludeman J.P., Stone M.J. The structural role of receptor tyrosine sulfation in chemokine recognition. Br. J. Pharmacol. 2014, 171:1167-1179.
50. Finnis M.L., Gibson M.A. Microfibril-associated glycoprotein-1 (MAGP-1) binds to the pepsin-resistant domain of the alpha3(VI) chain of type VI collagen. J. Biol. Chem. 1997, 272:22817-22823.
51. Brown-Augsburger P.B., Broekelmann T., Rosenbloom J., Mecham R.P. Functional domains on elastin and MAGP involved in elastic fiber assembly. Biochem. J. 1996, 318:149-155.
52. Kozel B.A., Rongish B.J., Czirok A., Zach J., Little C.D., Davis E.C., et al. Elastic fiber formation: A dynamic view of extracellular matrix assembly using timer reporters. J. Cell. Physiol. 2006, 207:87-96.
53. Trask B.C., Trask T.M., Broekelmann T., Mecham R.P. The microfibrillar proteins MAGP-1 and fibrillin-1 form a ternary complex with the chondroitin sulfate proteoglycan decorin. Mol. Biol. Cell 2000, 11:1499-1507.
54. Reinboth B., Hanssen E., Cleary E.G., Gibson M.A. Molecular interactions of biglycan and decorin with elastic fiber components: biglycan forms a ternary complex with tropoelastin and microfibril-associated glycoprotein 1. J. Biol. Chem. 2002, 277:3950-3957.
55. Craft C.S., Zou W., Watkins M., Grimston S., Brodt M.D., Broekelmann T.J., et al. Microfibril-associated glycoprotein-1, an extracellular matrix regulator of bone remodeling. J. Biol. Chem. 2010, 285:23858-23867.
56. Craft C.S., Broekelmann T.J., Zou W., Chappel J.C., Teitelbaum S.L., Mecham R.P. Oophorectomy-induced bone loss is attenuated in MAGP1-deficient mice. J. Cell. Biochem. 2012, 113:93-99.
57. Massam-Wu T., Chiu M., Choudhury R., Chaudhry S.S., Baldwin A.K., McGovern A., et al. Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF beta. J. Cell Sci. 2010, 123:3006-3018.
58. Segade F., Trask B.C., Broekelmann T., Pierce R.A., Mecham R.P. Identification of a matrix binding domain in MAGP1 and 2 and intracellular localization of alternative splice forms. J. Biol. Chem. 2002, 277:11050-11057.
59. Werneck C.C., Trask B.C., Broekelmann T.J., Trask T.M., Ritty T.M., Segade F., et al. Identification of a major microfibril-associated glycoprotein-1-binding domain in fibrillin-2. J. Biol. Chem. 2004, 279:23045-23051.
60. Penner A.S., Rock M.J., Kielty C.M., Shipley J.M. Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly. J. Biol. Chem. 2002, 277:35044-35049.
61. Miyamoto A., Donovan L.J., Perez E., Connett B., Cervantes R., Lai K., et al. Binding of MAGP2 to microfibrils is regulated by proprotein convertase cleavage. Matrix Biol. 2014, 40:27-33.
62. Albig A.R., Becenti D.J., Roy T.G., Schiemann W.P. Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells. Microvasc. Res. 2008, 76:7-14.
63. Nehring L.C., Miyamoto A., Hein P.W., Weinmaster G., Shipley J.M. The extracellular matrix protein MAGP-2 interacts with Jagged1 and induces its shedding from the cell surface. J. Biol. Chem. 2005, 280:20349-20355.
64. Weinbaum J.S., Tranquillo R.T., Mecham R.P. The matrix-binding domain of microfibril-associated glycoprotein-1 targets active connective tissue growth factor to a fibroblast-produced extracellular matrix. Macromol. Biosci. 2010, 10:1338-1344.
65. Guo M., Teng M., Niu L., Liu Q., Huang Q., Hao Q. Crystal structure of the cysteine-rich secretory protein stecrisp reveals that the cysteine-rich domain has a K+ channel inhibitor-like fold. J. Biol. Chem. 2005, 280:12405-12412.
66. Rock M.J., Cain S.A., Freeman L.J., Morgan A., Mellody K., Marson A., et al. Molecular basis of elastic fiber formation. Critical interactions and a tropoelastin-fibrillin-1 cross-link. J. Biol. Chem. 2004, 279:23748-23758.
67. Cain S.A., Baldwin A., Mahalingam Y., Raynal B., Jowitt T.A., Shuttleworth C.A., et al. Heparan sulfate regulates fibrillin-1 N- and C-terminal interactions. J. Biol. Chem. 2008, 283:27017-27027.
68. Hanssen E., Hew F.H., Moore E., Gibson M.A. MAGP-2 has multiple binding regions on fibrillins and has covalent periodic association with fibrillin-containing microfibrils. J. Biol. Chem. 2004, 279:29185-29194.
69. Combs M.D., Knutsen R.H., Broekelmann T.J., Toennies H.M., Brett T.J., Miller C.A., et al. Microfibril-associated glycoprotein 2 (MAGP2) loss of function has pleiotropic effects in vivo. J. Biol. Chem. 2013, 288:28869-28880.
70. Nistala H., Lee-Arteaga S., Smaldone S., Siciliano G., Carta L., Ono R.N., et al. Fibrillin-1 and -2 differentially modulate endogenous TGF-beta and BMP bioavailability during bone formation. J. Cell Biol. 2010, 190:1107-1121.
71. Gregory K.E., Ono R.N., Charbonneau N.L., Kuo C.L., Keene D.R., Bachinger H.P., et al. The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix. J. Biol. Chem. 2005, 280:27970-27980.
72. Sengle G., Ono R.N., Sasaki T., Sakai L.Y. Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability. J. Biol. Chem. 2011, 286:5087-5099.
73. Sengle G., Charbonneau N.L., Ono R.N., Sasaki T., Alvarez J., Keene D.R., et al. Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J. Biol. Chem. 2008, 283:13874-13888.
74. Ono R.N., Sengle G., Charbonneau N.L., Carlberg V., Bachinger H.P., Sasaki T., et al. Latent transforming growth factor beta-binding proteins and fibulins compete for fibrillin-1 and exhibit exquisite specificities in binding sites. J. Biol. Chem. 2009, 284:16872-16881.
75. Travis M.A., Sheppard D. TGF-beta activation and function in immunity. Annu. Rev. Immunol. 2014, 32:51-82.
76. Chen E., Larson J.D., Ekker S.C. Functional analysis of zebrafish microfibril-associated glycoprotein-1 (Magp1) in vivo reveals roles for microfibrils in vascular development and function. Blood 2006, 107:4364-4374.
77. Alvarez Y., Cederlund M.L., Cottell D.C., Bill B.R., Ekker S.C., Torres-Vazquez J., et al. Genetic determinants of hyaloid and retinal vasculature in zebrafish. BMC Dev. Biol. 2007, 7:114.
78. Shi Y., Tu Y., De Maria A., Mecham R.P., Bassnett S. Development, composition, and structural arrangements of the ciliary zonule of the mouse. Invest. Ophthalmol. Vis. Sci. 2013, 54:2504-2515.
79. Arteaga-Solis E., Sui-Arteaga L., Kim M., Schaffler M.B., Jepsen K.J., Pleshko N., et al. Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. Matrix Biol. 2011, 30:188-194.
80. Kitahama S., Gibson M.A., Hatzinikolas G., Hay S., Kuliwaba J.L., Evdokiou A., et al. Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cells. Bone 2000, 27:61-67.
81. Boyce B.F., Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res. Ther. 2007, 9. (Suppl. 1):S1.
82. Werneck C.C., Vicente C.P., Weinberg J.S., Shifren A., Pierce R.A., Broekelmann T.J., et al. Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury. Blood 2008, 111:4137-4144.
83. Weber E., Rossi A., Solito R., Agliano M., Sacchi G., Gerli R. The pattern of fibrillin deposition correlates with microfibril-associated glycoprotein 1 (MAGP-1) expression in cultured blood and lymphatic endothelial cells. Lymphology 2004, 37:116-126.
84. Gibson M.A., Cleary E.G. The immunohistochemical localization of microfibril-associated glycoprotein (MAGP) in elastic and non-elastic tissues. Immunol. Cell Biol. 1987, 65:345-356.
85. Mecham R.P., Madaras J., McDonald J.A., Ryan U. Elastin production by cultured calf pulmonary artery endothelial cells. J. Cell. Physiol. 1983, 116:282-288.
86. Birembaut P., Legrand Y.J., Bariety J., Bretton R., Fauvel F., Belair M.F., et al. Histochemical and ultrastructural characterization of subendothelial glycoprotein microfibrils interacting with platelets. J. Histochem. Cytochem. 1982, 30:75-80.
87. Fauvel F., Grant M.E., Legrand Y.J., Souchon H., Tobelem G., Jackson D.S., et al. Interaction of blood platelets with a microfibrillar extract from adult bovine aorta: requirement for von Willebrand factor. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:551-554.
88. Fauvel-Lafeve F., Legrand Y.J. Binding of plasma von Willebrand factor by arterial microfibrils. Thromb. Haemost. 1990, 64:145-149.
89. Legrand Y.J., Fauvel-Lafeve F. Molecular mechanism of the interaction of subendothelial microfibrils with blood platelets. Nouv. Rev. Fr. Hematol. 1992, 34:17-25.
90. Hautamaki R.D., Kobayashi D.K., Senior R.M., Shapiro S.D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997, 277:2002-2004.
91. Soler Artigas M., Loth D.W., Wain L.V., Gharib S.A., Obeidat M., Tang W., et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat. Genet. 2011, 43:1082-1090.
92. Craft C.S., Pietka T.A., Schappe T., Coleman T., Combs M.D., Klein S., et al. The extracellular matrix protein MAGP1 supports thermogenesis and protects against obesity and diabetes through regulation of TGF-beta. Diabetes 2014, 63:1920-1932.
93. Hoffmann K., Mattheisen M., Dahm S., Nurnberg P., Roe C., Johnson J., et al. A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2. Diabetologia 2007, 50:1418-1422.
94. Liu Y.J., Xu F.H., Shen H., Liu Y.Z., Deng H.Y., Zhao L.J., et al. A follow-up linkage study for quantitative trait loci contributing to obesity-related phenotypes. J. Clin. Endocrinol. Metab. 2004, 89:875-882.
95. Morris B.J. Dissecting hypertension by obesity identifies a locus at 1p36. Hypertension 2005, 46:1256-1258.
96. Pausova Z., Gaudet D., Gossard F., Bernard M., Kaldunski M.L., Jomphe M., et al. Genome-wide scan for linkage to obesity-associated hypertension in French Canadians. Hypertension 2005, 46:1280-1285.
97. Cs C. MAGP1, the extracellular matrix, and metabolism. Adipocyte 2014, 3(4):1-5.
98. Devlin M.J. The "Skinny" on brown fat, obesity, and bone. Am. J. Phys. Anthropol. 2015, 156:98-115. Suppl. 59.
99. Tan C.K., Chong H.C., Tan E.H., Tan N.S. Getting 'Smad' about obesity and diabetes. Nutr. Diet. 2012, 2:e29.
100. Yadav H., Quijano C., Kamaraju A.K., Gavrilova O., Malek R., Chen W., et al. Protection from obesity and diabetes by blockade of TGF-beta/Smad3 signaling. Cell Metab. 2011, 14:67-79.
101. Pereira L., Lee S.Y., Gayraud B., Andrikopoulos K., Shapiro S.D., Bunton T., et al. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:3819-3823.
102. Barisic-Dujmovic T., Boban I., Adams D.J., Clark S.H. Marfan-like skeletal phenotype in the tight skin (Tsk) mouse. Calcif. Tissue Int. 2007, 81:305-315.
103. Nistala H., Lee-Arteaga S., Carta L., Cook J.R., Smaldone S., Siciliano G., et al. Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome. Hum. Mol. Genet. 2010, 19:4790-4798.
104. Nistala H., Lee-Arteaga S., Smaldone S., Siciliano G., Ramirez F. Extracellular microfibrils control osteoblast-supported osteoclastogenesis by restricting TGFβ stimulation of RANKL production. J. Biol. Chem. 2010, 285:34126-34133.
105. Ramirez F., Dietz H.C. Fibrillin-rich microfibrils: Structural determinants of morphogenetic and homeostatic events. J. Cell. Physiol. 2007, 213:326-330.
106. Judge D.P., Dietz H.C. Marfan's syndrome. Lancet 2005, 366:1965-1976.
107. Graul-Neumann L.M., Hausser I., Essayie M., Rauch A., Kraus C. Highly variable cutis laxa resulting from a dominant splicing mutation of the elastin gene. Am. J. Med. Genet. A 2008, 146A:977-983.
108. Gibson M.A., Finnis M.L., Kumaratilake J.S., Cleary E.G. Microfibril-associated glycoprotein-2 (MAGP-2) is specifically associated with fibrillin-containing microfibrils but exhibits more restricted patterns of tissue localization and developmental expression than its structural relative MAGP-1. J. Histochem. Cytochem. 1998, 46:871-885.
109. Hatzinikolas G., Gibson M.A. The exon structure of the human MAGP-2 gene. J. Biol. Chem. 1998, 273:29309-29314.
110. Frankfater C., Maus E., Gaal K., Segade F., Copeland N.G., Gilbert D.J., et al. Organization of the mouse microfibril-associated glycoprotein-2 (MAGP-2) gene. Mamm. Genome 2000, 11:191-195.
111. Lemaire R., Korn J.H., Shipley J.M., Lafyatis R. Increased expression of type I collagen induced by microfibril-associated glycoprotein 2: novel mechanistic insights into the molecular basis of dermal fibrosis in scleroderma. Arthritis Rheum. 2005, 52:1812-1823.
112. Lemaire R., Bayle J., Mecham R.P., Lafyatis R. Microfibril-associated MAGP-2 stimulates elastic fiber assembly. J. Biol. Chem. 2007, 282:800-888.
113. Donovan L.J., Cha S.E., Yale A.R., Dreikorn S., Miyamoto A. Identification of a functional proprotein convertase cleavage site in microfibril-associated glycoprotein 2. Matrix Biol. 2013, 32:117-122.
114. Lemaire R., Farina G., Kissin E., Shipley J.M., Bona C., Korn J.H., et al. Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen. Arthritis Rheum. 2004, 50:915-926.
115. Albig A.R., Roy T.G., Becenti D.J., Schiemann W.P. Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis. Angiogenesis 2007, 10:197-216.
116. Alva J.A., Iruela-Arispe M.L. Notch signaling in vascular morphogenesis. Curr. Opin. Hematol. 2004, 11:278-283.
117. Ceder R., Haig Y., Merne M., Hansson A., Zheng X., Roberg K., et al. Differentiation-promoting culture of competent and noncompetent keratinocytes identifies biomarkers for head and neck cancer. Am. J. Pathol. 2012, 180:457-472.
118. Mok S.C., Bonome T., Vathipadiekal V., Bell A., Johnson M.E., Wong K.K., et al. A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell 2009, 16:521-532.
119. Spivey K.A., Banyard J. A prognostic gene signature in advanced ovarian cancer reveals a microfibril-associated protein (MAGP2) as a promoter of tumor cell survival and angiogenesis. Cell Adh. Migr. 2010, 4:169-171.
120. Leung C.S., Yeung T.L., Yip K.P., Pradeep S., Balasubramanian L., Liu J., et al. Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential. Nat. Commun. 2014, 5:5092.
121. Milwid J.M., Elman J.S., Li M., Shen K., Manrai A., Gabow A., et al. Enriched protein screening of human bone marrow mesenchymal stromal cell secretions reveals MFAP5 and PENK as novel IL-10 modulators. Mol. Ther. 2014, 22:999-1007.
122. Asseman C., Mauze S., Leach M.W., Coffman R.L., Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 1999, 190:995-1004.
123. Mead T.J., Yutzey K.E. Notch signaling and the developing skeleton. Adv. Exp. Med. Biol. 2012, 727:114-130.
124. Barbier M., Gross M.S., Aubart M., Hanna N., Kessler K., Guo D.C., et al. MFAP5 Loss-of-Function Mutations Underscore the Involvement of Matrix Alteration in the Pathogenesis of Familial Thoracic Aortic Aneurysms and Dissections. Am. J. Hum. Genet. 2014, 95:736-743.
125. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin-1. J. Cell Biol. 1995, 130:503-506.
126. Bornstein P., Sage E.H. Matricellular proteins: extracellular modulators of cell function. Curr. Opin. Cell Biol. 2002, 14:608-616.
127. Murphy-Ullrich J.E. The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?. J. Clin. Invest. 2001, 107:785-790.
128. Murphy-Ullrich J.E., Sage E.H. Revisiting the matricellular concept. Matrix Biol. 2014, 37:1-14.
129. Bonnefoy A., Daenens K., Feys H.B., De Vos R., Vandervoort P., Vermylen J., et al. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood 2006, 107:955-964.
130. Bradshaw A.D., Sage E.H. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J. Clin. Invest. 2001, 107:1049-1054.
131. Gooden M.D., Vernon R.B., Bassuk J.A., Sage E.H. Cell cycle-dependent nuclear location of the matricellular protein SPARC: Association with the nuclear matrix. J. Cell. Biochem. 1999, 74:152-167.